Lung cancer remains the world's deadliest cancer despite efforts to decrease smoking rates. Lung cancer screening (LCS) with low-dose computed tomography (LDCT) was shown to reduce lung cancer deaths by 20%. Screening with LDCT comes with potential harms including a high rate of false-positive test results, subsequent follow-up procedures, and radiation exposure. For some patients, the potential benefits associated with screening may be outweighed by the harms. The decision to screen must therefore take into consideration patients' risk of developing lung cancer, comorbidities that may prevent diagnostic procedures or curative surgery, and their values and preferences regarding the benefits and harms of screening. A process called shared decision-making (SDM) is recognized as a crucial feature of LCS. SDM is a patient-centered approach where healthcare providers provide best clinical evidence and then work together with patients to discern if the screening process aligns with the patient's values and preferences. Unfortunately, clinician SDM skills are often of poor quality which can lead to patients making uninformed decisions. Decision support tools that help patients make informed decisions and increase SDM on LCS are available. In 2015, the Centers for Medicare & Medicaid Services issued a coverage memo for LCS that contained an unprecedented requirement: an initial patient counseling and SDM visit with the use of at least one decision aid must occur for screening services to be reimbursed. This review focuses on SDM and suggests ways to increase the prevalence and effectiveness of SDM in LCS programs. Stopping smoking greatly reduces a person's risk for developing lung cancer, and smoking cessation messages in LCS guidelines from major medical organizations and interventions in LCS programs are explored. LCS has come of age; so too has SDM as it is an integral part of LCS programs.
Keywords: Decision aids; lung neoplasms; screening; shared decision-making (SDM); smoking cessation.
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Evaluating Shared Decision Making for Lung Cancer Screening.JAMA Intern Med. 2018 Oct 1;178(10):1311-1316. doi: 10.1001/jamainternmed.2018.3054. JAMA Intern Med. 2018. PMID: 30105393 Free PMC article.
What Exactly Is Shared Decision-Making? A Qualitative Study of Shared Decision-Making in Lung Cancer Screening.J Gen Intern Med. 2020 Feb;35(2):546-553. doi: 10.1007/s11606-019-05516-3. Epub 2019 Nov 19. J Gen Intern Med. 2020. PMID: 31745852
The Effects of Shared Decision Making on Cancer Screening – A Systematic Review [Internet].Washington (DC): Department of Veterans Affairs (US); 2014 Sep. Department of Veterans Affairs (US). 2014. PMID: 26290937 Free Books & Documents. Review.
Implementing Decision Coaching for Lung Cancer Screening in the Low-Dose Computed Tomography Setting.JCO Oncol Pract. 2020 Mar 24:JOP1900453. doi: 10.1200/JOP.19.00453. Online ahead of print. JCO Oncol Pract. 2020. PMID: 32208092
Shared Decision-making and Lung Cancer Screening: Let's Get the Conversation Started.Chest. 2019 Jan;155(1):21-24. doi: 10.1016/j.chest.2018.10.013. Epub 2018 Oct 22. Chest. 2019. PMID: 30359617 Review.
Cited by 5 articles
Effect of a Patient Decision Aid on Lung Cancer Screening Decision-Making by Persons Who Smoke: A Randomized Clinical Trial.JAMA Netw Open. 2020 Jan 3;3(1):e1920362. doi: 10.1001/jamanetworkopen.2019.20362. JAMA Netw Open. 2020. PMID: 32003822 Free PMC article.
Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium.Cancer Prev Res (Phila). 2020 Feb;13(2):129-136. doi: 10.1158/1940-6207.CAPR-19-0378. Epub 2019 Dec 23. Cancer Prev Res (Phila). 2020. PMID: 31871221
Incidence, prognostic factors, and a nomogram of lung cancer with bone metastasis at initial diagnosis: a population-based study.Transl Lung Cancer Res. 2019 Aug;8(4):367-379. doi: 10.21037/tlcr.2019.08.16. Transl Lung Cancer Res. 2019. PMID: 31555512 Free PMC article.
Effectiveness of a Patient Education Class to Enhance Knowledge about Lung Cancer Screening: a Quality Improvement Evaluation.J Cancer Educ. 2019 May 9:10.1007/s13187-019-01540-3. doi: 10.1007/s13187-019-01540-3. Online ahead of print. J Cancer Educ. 2019. PMID: 31073869
The impact of patients' preferences on the decision of low-dose computed tomography lung cancer screening.Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S236-S238. doi: 10.21037/tlcr.2018.08.17. Transl Lung Cancer Res. 2018. PMID: 30393611 Free PMC article. No abstract available.